JSM 2011 Online Program
The views expressed here are those of the individual authors and not necessarily those of the JSM sponsors, their officers, or their staff.
Activity Details
|
|||
645 | Thu, 8/4/2011, 10:30 AM - 12:20 PM | CC-A201 | |
Improving Designs and Analysis Methodologies in Clinical Trials — Topic Contributed Papers | |||
International Chinese Statistical Association | |||
Organizer(s): Xiaohong Huang, sanofi-aventis | |||
Chair(s): Zhenming Shun, sanofi-aventis | |||
10:35 AM | Classification of Endpoints and Strong Control of Type I Error Rates for Both Primary and Secondary Endpoints in Clinical Trials — Abdul J. Sankoh, Vertex Pharmaceuticals ; Haihong Li, Vertex Pharmaceuticals | ||
10:55 AM | Statistical Considerations for the Sequential Parallel Design — Roy N. Tamura, Eli Lilly and Company | ||
11:15 AM | Can the Line Between Primary and Secondary Endpoints Be Blurred? A Method to Adaptively Test Multiple Endpoints with Emerging Data — Yang Song, Merck & Co., Inc. | ||
11:35 AM | Design and Analysis of Crossover Trials for Absorbing Binary Endpoints — Martha Nason, National Institute of Allergy and Infectious Diseases ; Dean Follmann, National Institute of Allergy and Infectious Diseases | ||
11:55 AM | Floor Discussion |
2011 JSM Online Program Home
For information, contact jsm@amstat.org or phone (888) 231-3473.
If you have questions about the Continuing Education program, please contact the Education Department.